229 related articles for article (PubMed ID: 35721429)
21. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of post-COVID invasive rhino-orbito-cerebral mucormycosis and its outcomes: Role of neurosurgeons in a tertiary care center.
Das AK; Mani SK; Singh SK
Surg Neurol Int; 2022; 13():335. PubMed ID: 36128146
[TBL] [Abstract][Full Text] [Related]
23. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India.
Verma V; Sarkar D; Moharana B; Singh P; Noyadu R; Sharma B
Indian J Ophthalmol; 2023 Dec; 71(12):3669-3676. PubMed ID: 37991302
[TBL] [Abstract][Full Text] [Related]
24. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
25. Pott's puffy tumor: An unusual complication of rhino-orbito-cerebral mucormycosis.
Abraham AP; Manesh A; Regi S; Michael JS; Kumar RH; Thomas M; Cherian LM; Varghese L; Kurien R; Moorthy RK; Nair BR; Rajshekhar V; Rupa V
World Neurosurg X; 2024 Jul; 23():100387. PubMed ID: 38746040
[TBL] [Abstract][Full Text] [Related]
26. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
[TBL] [Abstract][Full Text] [Related]
27. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
28. COVID-19-related Rhino-orbital-cerebral Mucormycosis.
Al-Ani RM; Al Tameemi KM
Qatar Med J; 2022; 2022(4):47. PubMed ID: 36258686
[TBL] [Abstract][Full Text] [Related]
29. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
[TBL] [Abstract][Full Text] [Related]
30. Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital.
Kumari A; Rao NP; Patnaik U; Malik V; Tevatia MS; Thakur S; Jaydevan J; Saxena P
Med J Armed Forces India; 2021 Jul; 77(Suppl 2):S289-S295. PubMed ID: 34334896
[TBL] [Abstract][Full Text] [Related]
31. Rhino-orbito-cerebral mucormycosis following penetrating keratoplasty.
Raffa LH
J Surg Case Rep; 2019 Nov; 2019(11):rjz314. PubMed ID: 31832132
[TBL] [Abstract][Full Text] [Related]
32. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
[TBL] [Abstract][Full Text] [Related]
34. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
[TBL] [Abstract][Full Text] [Related]
35. Role of histopathology in severity assessments of post-COVID-19 rhino-orbital cerebral mucormycosis - A case-control study.
Shanmugasundaram S; Ramasamy V; Shiguru S
Ann Diagn Pathol; 2023 Dec; 67():152183. PubMed ID: 37696132
[TBL] [Abstract][Full Text] [Related]
36. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
Mani S; Thirunavukkarasu A
Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
[TBL] [Abstract][Full Text] [Related]
37. Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study.
Vidhyadevi R; Saudhamini S; Padmanaban S; Sundar D; Kannappan S; Suryaprabha G
J Curr Ophthalmol; 2022; 34(4):460-464. PubMed ID: 37180537
[TBL] [Abstract][Full Text] [Related]
38. Rhino-orbital-cerebral mucormycosis.
Gamaletsou MN; Sipsas NV; Roilides E; Walsh TJ
Curr Infect Dis Rep; 2012 Aug; 14(4):423-34. PubMed ID: 22684277
[TBL] [Abstract][Full Text] [Related]
39. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
40. Rhino Orbital Cerebral Mucormycosis in Covid-19 Crisis.
Vadivel S; Gowrishankar M; Vetrivel K; Sujatha B; Navaneethan P
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):1014-1020. PubMed ID: 36855632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
